Peroxiredoxin post-translational modifications by redox messengers  by Riquier, Sylvie et al.
Peroxiredoxin post-translational modiﬁcations by redox messengers
Sylvie Riquier a, Jacques Breton a, Kahina Abbas a, David Cornu b,c,
Cécile Bouton a, Jean-Claude Drapier a,n
a Institut de Chimie des Substances Naturelles, UPR2301 CNRS, 91190 Gif-sur-yvette, France
b Imagif Platform, FRC 3115, 91190 Gif-sur-Yvette, France
c University Paris-Sud, 91405 Orsay, France
a r t i c l e i n f o
Available online 5 June 2014
Keywords:
Peroxiredoxins
Hydrogen peroxide
Nitric oxide
Cysteine oxidation
Homocysteinylation
Macrophages
a b s t r a c t
Peroxiredoxins (Prxs) are a family of thiol peroxidases that participate in hydroperoxide detoxiﬁcation
and regulates H2O2 signaling. In mammals, the four typical 2-Cys Prxs (Prxs 1, 2, 3 and 4) are known to
regulate H2O2-mediated intracellular signaling. The 2 catalytic cysteines of 2-Cys Prxs, the so-called
peroxidatic and resolving cysteines, are regulatory switches that are prone to react with redox signaling
molecules. We investigated the respective modiﬁcations induced by H2O2, NO and H2S in the murine
macrophage cell line RAW264.7 by mass spectrometry and immunoblotting after separating 2-Cys Prxs
by one-dimensional or two-dimensional PAGE. We found that H2S, unlike NO, does not prevent H2O2-
mediated sulﬁnylation of 2-Cys Prxs and that Prx2 is more sensitive to NO-mediated protection against
sulﬁnylation by peroxides. We also observed that cells exposed to exogenous NO, released by Cys-SNO or
DETA-NO, or producing NO upon stimulation by IFN-γ and LPS, present an acidic form of Prx1 whose
modiﬁcation is consistent with S-homocysteinylation of its peroxidatic cysteine.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Reactive oxygen species (ROS) act as intracellular signaling
molecules, but can also exert a cytotoxic effect (lipid peroxidation,
protein and DNA oxidation). Cells have protective mechanisms
against these stressor molecules. Over the last decade, numerous
studies have pointed to the prominent role of the peroxiredoxin
(Prx) family in peroxide detoxiﬁcation and control H2O2 signaling.
Prxs are thiol peroxidases conserved in all kingdoms. Prxs are
ubiquitous enzymes, both abundant and catalytically efﬁcient
[1–3]. In mammals, the Prx family is composed of typical 2-Cys
Prx (1–4), an atypical 2-Cys Prx (Prx5) and one 1-Cys-Prx (Prx6).
All 2-Cys Prxs contain 2 cysteines at the active site. One of these
cysteines is referred to as a “peroxidatic” cysteine (Cp). In the
classic peroxidatic cycle, this cysteine is oxidized to a sulfenic
acid and forms an intermolecular (typical) or an intramolecular
(atypical) disulﬁde with the second catalytic (resolving) cysteine
(Cr) before regeneration of a reduced enzyme by the Trx/TrxR
system. As regards Prx6, it is held that glutathione is the reductant
that re-activates the enzyme.
There is a growing body of evidence that Prx post-translational
modiﬁcations including phosphorylation, acetylation, glutathiony-
lation and thiol oxidation, play a major role in Prx activities [4,5].
Notably, eukaryotic 2-Cys Prxs are susceptible to thiol sulﬁnyla-
tion, often referred to as overoxidation, due to the low rate of
disulﬁde formation between Cp and Cr. The rationale of this
transient oxidative inactivation of 2-Cys Prxs is still debated.
According to the ﬂoodgate model proposed by Poole and
co-workers, reversible loss of 2-Cys Prx activity allows cells to
adjust the amount of intracellular H2O2 required for local signaling
events [6]. Besides, recent studies revealed that 2-Cys Prx sulﬁny-
lation in yeast is important to maintain Trx in a reduced state to
repair oxidized protein [7,8]. Reversible sulﬁnylation of 2-Cys Prxs
is also responsible for a switch between dimers (active peroxidase
form) and high molecular weight complexes, which display a
chaperone activity [9]. Again, the redox status of the peroxidatic
cysteine is pivotal in determining 2-Cys Prx function.
Studies investigating the redox state of 2-Cys Prxs by 2-D and
mass spectrometry analyses revealed that Prx sulﬁnylation is
reversible in eukaryotic cells [10,11]. Indeed, a Prx sulﬁnyl reduc-
tase called sulﬁredoxin (Srx), the “Prx repair enzyme” was found
in eukaryotes [12]. The rate of reduction of overoxidized 2-Cys
Prxs by Srx is relatively slow, which is interpreted as the time
required for H2O2 to perform signaling. Srx transcriptional expres-
sion is up-regulated via AP-1 or Nrf2 [12]. Interestingly, it was
recently shown that 2-Cys Prx reversible sulﬁnylation is a
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conserved marker of a non-transcriptional circadian rhythm [13].
Therefore, it is conceivable that 2-Cys Prxs physiologically oscillate
between two states, i.e., the reduced, active form and the sulﬁny-
lated, inactive form, whose ratio mainly depends on H2O2 ﬂuxes
and Srx expression and activity.
We have previously shown that nitric oxide (NO) produced
under physiological conditions increases Srx expression at the
transcriptional level in primary mouse macrophages [14]. This was
the ﬁrst time that Srx expression was found to be signal-
dependent. We also showed that the level of sulﬁnylated 2-Cys
Prxs is kept high in cells from Srx KO mice. Moreover, in
macrophages, we found that Srx induction is dependent on Nrf2
[15]. in vivo experiments have indicated that Srx KO mice display
high sensitivity to LPS-induced endotoxic shock and increased
alcoholic liver injury [16]. We have also shown that NO reduces
the level of H2O2-induced sulﬁnylation of 2-Cys Prxs in an Srx-
independent manner in murine macrophages [14]. At the same
time, it was reported that NO promotes S-nitrosylation of Prx2 of
mammalian neurons, thus preventing hydrogen peroxide reduc-
tion [17]. Therefore, NO can act rapidly to target 2-Cys Prxs and, in
a time delayed manner, by increasing expression of Srx [14].
There is a lot of evidence that reactive nitrogen species (RNS)
and ROS are commonly produced by a large variety of cell types in
response to both physiological stimuli and physio(patho)logical
situations [18,19] by the Nox/Duox family and by the NOS iso-
forms, respectively. It is therefore not surprising that a growing
number of reports deal with redox modiﬁcations of thiol- or
metal-containing proteins. NO forms nitrous anhydride (N2O3) in
the presence of oxygen. N2O3 is considered as a major nitrosylating
species. S-nitrosylation also occurs by transnitrosylation. S-
nitrosothiols (SNO) are generally very labile and can react with
other thiols. Alternatively, consistent with the fact that NO has a
strong afﬁnity for transition metals, particularly iron, dinitrosyl-
iron complexes can also promote S-nitrosylation of cysteines in
proteins [20]. Over the last few years, H2S has emerged as novel
gasotransmitter in mammals beside NO and CO [21]. H2S is largely
formed from cysteine metabolism by two pyridoxal phosphate
enzymes, cystathionine β-synthase (CBS) and cystathionine γ-lyase
(CSE) [22]. Murine macrophages display high expression of CSE in
response to stimulation by LPS [23]. In mammalian cells, cysteine
residues on proteins can be modiﬁed by H2S, which like H2O2 and
NO, can react with thiols with low pKa (thiolates) [24]. It is
therefore likely that H2O2, NO and H2S can compete for the same
reactive cysteine of Prxs.
In this study, we assessed the respective roles of H2O2 and NO
on 2-Cys Prx by 2-D gel electrophoresis followed by mass spectro-
metry or immunodetection. The possible effect of H2S on 2-Cys Prx
sulﬁnylation by H2O2 was also evaluated. We show that the 2-Cys
Prxs react differently to NO and to H2O2 and provide the ﬁrst
evidence for potential effect of NO on homocysteinylation of the
catalytic cysteine of Prx1.
Material and methods
Reagents
CHAPS, 1,4 dithio-DL-threitol (DTT), iodoacetamide (IAM),
sodium dodecyl sulfate (SDS), peroxide solution 30%, protease
inhibitor cocktail, bicinchoninic acid, bromophenol blue, phos-
phate buffer saline (PBS), Tween 20, glycerol, gentamicin, DMEM,
fetal bovine serum and D-L-propargylglycine were from Sigma-
Aldrich. Chemicals for casting SDS-PAGE gels were from Bio-Rad.
The NO donor (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]
diazen-1-ium-1,2-diolate (DETA-NONOate) was from Cayman Che-
mical (Ann Arbor, MI). Readyprep 2-D Cleanup Kit, immobilized pH
gradient (IPG) buffer 3–10 and 7–10, Ready IPG strips 11 and 17 cm,
pH 3–10 nonlinear, urea, thiourea were from Bio-Rad. The colloidal
blue staining kit was from Invitrogen, Life Technologies.
S-nitrosocysteine (Cys-NO) was prepared as described [25].
Cell culture
The RAW264.7 macrophage cell line was from ATCC. Recombi-
nant mouse interferon-gamma (IFN-γ, speciﬁc activity 8.4106
U/mg) was from R&D Systems (Abingdon, UK). Escherichia coli
lipopolysaccharide (LPS) TLR4 grade was from Alexis Biochemicals.
Cell viability was determined by Trypan blue exclusion. Cells
were cultured in DMEM supplemented with 10% FBS, gentamicin
(100 mg/mL) at 37 1C under 5% CO2.
Antibodies and immunoblot analyses
Anti-2-Cys Prx, anti-Prx1 and anti-2-Cys Prx-SO2/3 antibodies
were from Abcam, and anti-vinculin antibody was from Sigma-
Aldrich. Fluorescent secondary antibodies coupled to IRDye
680CW or 800CW were from LI-COR Biosciences. Cells were
washed two times with cold PBS and lysed in 0.5% Triton X-100
in 25mM Tris, pH 7.4, 50mM NaCl, 2mM EDTA containing
Protease Inhibitor Cocktail (Sigma-Aldrich). Cell lysates were then
centrifuged at 10,000g at 4 1C for 10min, and the protein content
of the supernatant was determined spectrophotometrically at 562
nm by using the bicinchoninic protein assay. Cell lysates were
fractionated by SDS-PAGE in 12% polyacrylamide gel under redu-
cing conditions. Proteins were blotted onto nitrocellulose mem-
branes (Amersham-GE Healthcare), blocked with Odyssey
blocking buffer (LI-COR Biosciences, Lincoln, NE), and incubated
with primary antibodies. Vinculin and actin were used as loading
controls. Proteins were then visualized with ﬂuorescent secondary
antibodies coupled to IRDye 680CW. Infrared ﬂuorescence was
measured by scanning the plate using the Odyssey Imaging System
(LI-COR Biosciences, Lincoln, NE).
Nitrite measurement
Nitrite, the stable end product of NO, was quantiﬁed in culture
medium using the Griess reagent. Brieﬂy, 200 mL of medium was
reacted with 800 mL of Griess reagent (0.5% sulfanilamide and
0.05% N-(1-naphthyl)-ethylenediamine from Sigma-Aldrich in 45%
acetic acid), and the absorbance was measured at 543 nm. The
nitrite concentration was determined from a sodium nitrite
standard curve.
Two-dimensional electrophoresis analysis
After precipitation by 2D cleanup (Bio-Rad), 250 mg of protein
was diluted in 150 mL of a rehydration buffer containing 7M urea,
2M thiourea, 4% CHAPS, 50 mM DTT, 1% IPG buffer pH 3–10 and
3 mL of 0.25% bromophenol blue. Samples were loaded on 11-cm
immobilized pH gradient IPG strips with a nonlinear gradient of
pH 3–10 for 2 h at room temperature. Isoelectric focusing was
performed at 20 1C with a Protean isoelectric focusing cell
(Bio-Rad). Strips were equilibrated for 15min in 5mL of the
equilibration solution (6M urea, 375 mM Tris–HCl pH 8.8, 20%
glycerol, 2% SDS) containing 20mg/mL DTT, then for another 15
min in 5mL of the equilibration solution containing 25mg/mL
iodoacetamide, in the dark. Separation in the second dimension
was performed on SDS-PAGE (12% acrylamide) using a Criterion
Cell (Bio-Rad). The proteins were stained with the Colloidal blue
kit (Invitrogen).
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MALDI-MS analyses
Protein digestion and peptide identiﬁcation by MALDI-MS were
performed as described [26]. Brieﬂy, MALDI TOF–TOF spectra were
acquired in the positive and reﬂector mode, and an external
calibration was performed using an equal mix of standard
peptide solution Cal mix 1 and Cal mix 2 (Applied Biosystems).
Monoisotopic peptide mass values extracted by Data Explorer
(Applied Biosystems) were used for protein identiﬁcation by
searching against the UniProtKB/Swiss-Prot database using the
on-line mascot search engine (http://www.matrixscience.com). The
searches were conducted using the following settings: trypsin as
digestion enzyme, one missed cleavage allowed, 30 ppm tolerance,
carbamidomethyl as ﬁxed modiﬁcation and methionine oxidation
as variable modiﬁcation.
NanoLC–MS/MS analyses
After separation on 2D-gel electrophoresis, spot excision and
in-gel digestion, samples were analyzed by mass spectrometry.
In some experiments, samples were again reduced with 50 mL of
10mM DTT at 56 1C and then alkylated with 50 mL of 55mM
iodoacetamide (carbamidomethylation) for 45min at room tem-
perature before addition of trypsin (Trypsin Gold, Promega).
Extracted peptides were vacuum dried and resuspended in 5%
formic acid prior to mass spectrometry analyses. LC–MS/MS
analyses were performed with the Triple-TOF 4600 mass spectro-
meter (AB Sciex) coupled to the nanoRSLC system (Thermo
Scientiﬁc) equipped with a trap column (Acclaim PepMap100C18,
75 μm i.d. 2 cm, 3 mm) and an analytical column (Acclaim Pep-
MapRSLCC18, 75 μm i.d.15 cm, 2 mm, 100 Å). The loading buffer
was an H2O/CH3CN/TFA (98%/2%/0.05%), and buffers A and B were
0.1% formic acid in water and 0.1% formic acid in CH3CN, respec-
tively. Peptides were eluted at a ﬂow rate of 300 nL/min from the
reverse phase C18 column using a 5–35% CH3CN gradient for 40
min. MS/MS spectra were acquired with a Data Dependent
acquisition method by selecting the 10 most intense precursors
for CID fragmentation with Q1 quadrupole set at low resolution for
better sensitivity. Raw data were processed with MS Data Con-
verter software for generating MGF data ﬁles and analyzed with
PeakView software (AB Sciex). Protein identiﬁcation searches were
performed using the MASCOT algorithm considering carbamido-
methylation of cysteines and oxidation of methionines as variable
modiﬁcations. Peptide and fragment tolerance were respectively
set at 10 ppm and 0.01 Da. Second pass search was performed by
Mascot Error Tolerant algorithm for untargeted identiﬁcations of
potential modiﬁed peptides. The list of modiﬁcations used by
Mascot was taken directly from the Unimod database, and only
ions with a score higher than the identity threshold (determined
at ﬁrst pass search) less than 1% of false positive discovery rate
using the decoy option in Mascot, were considered.
Two-color Western blot detection
Fluorescent Western blots were performed as described [26].
Brieﬂy, proteins were resolved by SDS-PAGE and transferred onto
Immobilon-FL PVDF membrane at 100mA/gel for 90min in a
Trans-Blot cell (Bio-Rad). Transfer buffer: 12.5mM Tris–HCl, 96
mM glycine, 20% ethanol. Membranes were blocked in 5% skim
milk in TBST20 (150mM NaCl, 50mM Tris–HCl pH 8 and 0.05%
Tween 20). Two-color detection of the different forms of Prxs
was achieved by multiplexing IRDye 800CW and IRDye 680CW
conjugates. The membranes were incubated overnight at 4 1C with
a primary antibody against Prx-SO2/3 (Abcam ab16830) at 1:5000
dilution in TBST20. Images were scanned with an Odyssey scanner
(LI-COR Biosciences).
CSE detection
Cells were exposed to 20 ng/mL LPS overnight, and after
washing, they were challenged with 100 mM H2O2 for 20min. Cell
were harvested in Triton X-100 lysis buffer: 50mM Tris–HCl
(pH 7.5), 0.5% TRIS Triton X-100, protease inhibitor cocktail, and
lysates were fractionated by SDS-PAGE in 12% polyacrylamide gels
under reducing conditions. After electrophoresis and protein
immobilization, polyvinylidene diﬂuoride membranes (Millipore)
were blocked with nonfat milk and incubated with primary
antibodies: anti-CSE (CTH 30.7) monoclonal antibody from Santa
Cruz, anti-β-actin from Sigma-Aldrich, and anti-2-Cys Prx-SO2/3
and anti-2-Cys Prx antibodies from Abcam. Protein bands
were visualized and quantiﬁed with the Odyssey scanner (LI-COR
Biosciences).
Results and discussion
Cysteine residues are favorite targets of redox-active molecules
[27]. Thiol-based redox control of proteins by H2O2, NO or H2S
is therefore involved in many signaling pathways. Over the
last decade, H2S has emerged as a regulator of mammalian cell
signaling by mediating sulfhydration of cysteines on proteins [28].
H2S modiﬁes speciﬁc cysteine residues in proteins by forming a
persulﬁde (SSH), a modiﬁcation referred to as sulfhydration [21].
It has been reported that proteins are sulfhydrated at reactive
cysteines, which are also S-nitrosylated, including GAPDH [29] and
the p65 subunit of NF-κB [30]. As thiols (or rather thiolates) that
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Fig. 1. Expression of CSE, and effect of Na2S on 2-Cys Prx sulﬁnylation. A, Left,
RAW264.7 cells were left untreated or stimulated for 16 h with 200 ng/mL LPS for
16 h. Cell lysates were run on SDS-PAGE and immunoblotted for CSE. (A) Right,
RAW264.7 cells were left untreated or stimulated for 16 h with 200 ng/mL LPS for
16 h in the presence or absence of 1mM PAG. After exhaustive washing, cells were
challenged with 100 mM H2O2 for 20min. Cell lysates were run on SDS-PAGE and
immunoblotted for 2-Cys Prx-SO2/3. (B) RAW264.7 cells were exposed to Na2S for
30min and, after washing, to 100 mM H2O2 for 20min. Lysates were collected, and
2-Cys Prx-SO2/3 expression was analyzed by immunoblotting using a speciﬁc
antibody. Anti-β-actin antibody was used as a loading control. Results are
representative of 3 independent experiments.
S. Riquier et al. / Redox Biology 2 (2014) 777–785 779
are prone to be S-nitrosylated can also be sulfhydrated [30], we
wondered whether H2S could react, like NO, with redox active
cysteines of Prxs, and reduce the level of sulﬁnylation.
We ﬁrst tested the capacity of LPS-stimulated RAW264.7 cells
to express CSE, the H2Sproducing enzyme in macrophages.
As shown in Fig. 1A, left, stimulation of cells by 100 ng/mL LPS
induced robust expression of CSE. Cells were also exposed to
20 ng/mL LPS in the presence or absence of DL-propargyl-glycine
(PAG), an inhibitor of CSE. Fig. 1, right, shows that treatment with
LPS reduces the level of Prx2-SO2 in cells, whether they are
challenged with H2O2 or not. As LPS induces NO synthase 2 in
murine macrophages, it is likely that NO counteracted the effect of
H2O2 as already described [14]. The presence of PAG did not
change the level of remaining sulﬁnylated Prx1/Prx2 (co-migrating
on this gel), suggesting that H2S endogenously produced by LPS-
stimulated RAW cells, if any, does not modify 2-Cys Prx sulﬁnyla-
tion by H2O2. In addition, we also exposed cells to Na2S (an H2S
donor) and H2O2 added in sequence, and assessed the level of
sulﬁnylation by immunoblot. As shown in Fig. 1B, Na2S added
either after or before did not preclude H2O2-mediated Prx sulﬁ-
nylation. Whether or not exposure of cells to Na2S elicited
sulfhydration of 2-Cys Prxs was not determined, but our results
suggest that H2S, in contrast to NO, does not interfere with 2-Cys
Prx sulﬁnylation by H2O2.
To detect 2-Cys Prx modiﬁcations by H2O2 and NO, whole-cell
lysates of resting RAW264.7 macrophages were analyzed by 2-D
01Hp3Hp
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Fig. 2. Two-dimensional gel electrophoresis coupled to mass spectrometry or
immunodetection for Prx identiﬁcation. (A) Proteins (500 mg) extracted from
RAW264.7 cells were separated by two-dimensional electrophoresis on 17-cm
strip 3–10 NL pH gradients. Strips were loaded on 12% SDS-PAGE. The gel was
stained with colloidal Coomassie blue, and 2-Cys Prx spots (indicated by arrows)
were identiﬁed by MALDI-TOF. (B and C) Region of the 2-D gels containing the
2-Cys Prxs. Cell extracts (600 mg of protein) were prepared from RAW264.7 cells,
either untreated (control) or exposed to 100 mM H2O2 for 20min with or without a
16-h pre-exposure to 500 mM DETA-NO. (B) Cell lysates were analyzed by 2-D SDS-
PAGE gel followed by MALDI mass spectrometry. Spots corresponding to Prx 1
(basic pI) and Prx2 (acidic pI) are circled in red and marked with an arrow. Prx3 and
Prx4 were not identiﬁed. (C) Cell extracts were analyzed by 2-D SDS-PAGE and
2-color immunodetection using an anti-Prx-SO2/3 antibody (green color), and anti-
2-Cys Prx and anti-Prx1 antibodies (red color). Additionally, anti-Prx1 antibody
(red color) was also incubated with the membrane to maximize Prx1 signal. The
yellowish-orange spots show an overlay of the reduced (red) and overoxidized
(green) 2-Cys Prxs. White asterisks indicate extraneous spot artifacts.
pH 10 pH 7
Control
H2O2
DETA-NO
H2O2
after NO priming
Control
Cys-NO
Control
IFN-γ/LPS
DETA NO-
Fig. 3. Variation of Prx1 in RAW264.7 cells after treatment with H2O2 or NO. (A–C)
Cell extracts were separated by 2-D gel on 11-cm strip 7–10 NL pH gradients
followed by immunodetection. Only the region of the gel containing Prx1 (basic pI)
is shown. A, Extracts from cells exposed to DETA-NO or H2O2 or to both added in
sequence (as described in Fig. 2). Original (reduced) Prx1 and sulﬁnylated Prx1
spots were detected with an anti-Prx1 antibody (red) and an anti-2-Cys Prx-SO2/3
antibody (green), respectively. (B) Lysates prepared from RAW264.7 cells exposed
to 400 mM Cys-NO in HBBS for 30min at 37 1C. The various forms of Prx1 were
detected with an anti-Prx1 antibody. (C) Lysates prepared from RAW264.7 cells
were stimulated with 20 U/mL IFN-γ and 200 ng/mL LPS or exposed to 500 mM
DETA-NO for 16 h. The various forms of Prx1 were detected with an anti-Prx1
antibody. Original Prx1 spots were labeled with an arrow pointing up whereas
acidic-shifted spots were labeled with an arrow pointing down.(For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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SDS-PAGE, and spots corresponding to 2-Cys Prxs 1, 2, 3, 4 were
visualized on the gel with colloidal blue (Fig. 2A) and identiﬁed
by MALDI-MS [26]. In macrophages, Prx5 is inducible at the
transcriptional level by immune stimuli [31] and therefore was
not detectable under these conditions. As shown in Fig. 2B, the
migration shifts of Prx1 and Prx2 (circled in red) were compared in
RAW264.7 macrophages exposed to either H2O2 or NO alone or to
both applied successively. Most of the Prx1 and a signiﬁcant
percentage of Prx2 underwent an acidic shift following exposure
to 100 mM H2O2, which has been attributed to their sulﬁnylated
form [10,11]. Treatment of cells by DETA-NO a diazeniumdiolate
that releases NO at low rate, did not change the spot pattern
around Prx2, but resulted in a new Prx1 spot that shifted to a more
acidic position similar to that of sulﬁnylated Prx1. When cells were
pre-incubated with DETA-NO before exposure to H2O2, the major
Prx1 spot corresponding to the reduced form was not shifted, and
only a minor spot was visible at the acidic migration position.
As regards Prx2, only the spot corresponding to the reduced form
was detectable. The effect of prior treatment of NO on the impact
on Prx1 and Prx2 of tert-butylhydroperoxide (tert-BHP), a
strong inducer of oxidative stress, was also investigated. Data in
Supplemental Fig. 1 shows that DETA-NO partially prevented
acidic shift of Prx2, whereas the level of the Prx1 acidic spot
remained unchanged. We also performed 2-D SDS-PAGE combined
with two-color ﬂuorescent immunoblots to increase sensitivity of
the assay and more easily detect the modiﬁed forms of 2-Cys Prxs.
Prxs detected by incubation with an anti-2-Cys Prx antibody
followed by secondary incubation with an anti-rabbit IgG coupled
to IRDye 680, ﬂuoresce red. Sulﬁnylated 2-Cys Prxs (Prx1, 2, 3 and
4) that are detected using an anti-sulﬁnylated 2-Cys Prx antibody
and an anti-mouse secondary antibody coupled with an IRDye
800, ﬂuoresce green. As shown in Fig. 2C, the orange spots that are
shifted leftward show overlays of the total Prx (red) and the
sulﬁnylated forms of Prx (green).
Taken together, these results suggest that Prx2 and Prx3 were
sulﬁnylated (or overoxidized) by H2O2 more easily than Prx1,
whereas Prx4 appeared to be the most resistant to sulﬁnylation.
Treatment of cells by DETA-NO conﬁrmed the acidic shift of a Prx1
spot, which does not react with the anti-Prx-SO2/3 antibody, and
appears red. Therefore, the NO-donor DETA-NO induces a mod-
iﬁcation of Prx1, which is not a sulﬁnylation even though its
migration toward the positive/acidic side is similar to that of a
sulﬁnylated form. None of the other 2-Cys Prxs exhibited another
notable shifted form, suggesting that Prx1 is more prone to
modiﬁcation by DETA-NO than other 2-Cys Prxs. Pre-exposure to
DETA-NO largely prevented Prx2 sulﬁnylation and, to a lesser
extent, Prx1 sulﬁnylation. Prx1 is therefore modiﬁed differently by
H2O2 and NO, and among the four 2-Cys Prxs, Prx2 appears to be
the most sensitive to an NO-dependent prevention of sulﬁnylation.
To obtain a more accurate view of the modiﬁcations of Prx1
brought about by H2O2 and/or NO, the ﬁrst-dimension isoelec-
trofocusing was performed with pH 7–10 IPG strips. Original Prx1
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3
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Fig. 4. Inhibition of HDAC activity does not preclude abatement of NO-dependent
sulﬁnylation of 2-Cys Prxs. RAW264.7 cells were cultured in the presence of
trichostatin A (TSA) for 16 h to inhibit HDAC activity or 500 mM DETA-NO after
washings, cells were challenged with 100 mM H2O2 for 20min. Cell lysates were
analyzed for expression of 2-Cys Prx-SO2 by immunoblotting.
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Fig. 5. The pattern of different isoelectric shifts of Prx1 in cells exposed to NO.
RAW264.7 cells were exposed to 400 mM Cys-NO for 30min in HBSS (A), or cultured
for 16h with 500 mMDETA-NO (B) or with a combination of 20U/mL IFN-γ and 200ng/
mL LPS (C). When indicated, cell lysates were treated with 5mM ascorbate and 10 mM
CuSO4 for 40min at 37 1C. Cell lysates were then analyzed by 2-D SDS-PAGE and by
immunodetection using an anti-Prx1 antibody and secondary antibodies coupled to
IRDye 700. Images were collected and analyzed by using the LI-COR Odyssey infrared
imaging system (Biosciences, Lincoln, NE, USA). Spots sensitive to ascorbate/copper are
circled and marked by an open arrowhead pointing up (A and C), while the ascorbate/
copper-resistant spot was referred to as X. Streaking toward the acidic extremity of the
gel, where Prx2 is positioned, precluded proper interpretation.
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spot (unshifted) is labeled by an arrow pointing up, whereas new
protein spots appearing to the left (i.e., more acidic) are labeled
with an arrow pointing down. Fluorescent immunoblots highlight
the fact that exposure to DETA-NO (Fig. 3A) or to Cys-NO, a
powerful S-nitrosating agent (Fig. 3B), modiﬁes Prx1, which in
turn shifts leftward toward a more acidic position. This satellite
spot does not react with an anti-Prx-SO2/3 antibody, which high-
lights that NO-modiﬁed Prx1 is not sulﬁnylated. It is also notable
that NO-modiﬁed spot shifted slightly less far than the spot
corresponding to the sulﬁnylated form of Prx1 in H2O2-exposed
cells (Fig. 3A).
We then questioned whether Prx1 was also modiﬁed in living
cells producing NO. RAW264.7 macrophages were incubated with
100 U/mL IFN-γ and 200 ng/mL LPS to stimulate expression of NO
synthase 2 and production of endogenous NO. As shown in Fig. 3C,
stimulation of macrophage NO production resulted in an acidic
shift of Prx1 identical to that generated by NO donors, underlining
the biological relevance of this Prx1 modiﬁcation. From now, this
spot will be referred to as spot X.
The shift of a protein to a more acidic position in 2-D gels is
compatible with the addition of a negative charge or loss of a
positive charge. Acetylation of Prx1, by neutralization of the lysine
positive charge, could induce acidic migration consistent with
the position of the left-shifted spot seen with NO-treated cells.
Interestingly, HDAC6 is a speciﬁc deacetylase of Prx1 and Prx2, and
acetylated Prx1 is more resistant to inactivation by H2O2 than the
unmodiﬁed form of the protein [32]. As NO is known to inhibit
HDAC [33], we asked whether pharmacological inhibition of
HDAC6 could reproduce the lessening by NO of H2O2-dependent
2-Cys Prx sulﬁnylation. As shown in Fig. 4, pre-incubation of
macrophages with trichostatin (TSA, a potent HDAC inhibitor),
did not abrogate H2O2-mediated strong sulﬁnylation of 2-Cys Prxs
(lane 4), while it induced tubulin acetylation, which was taken as a
positive control (not shown). These data suggest that acetylation
of Prx1, if any, does not interfere with oxidative inactivation of
2-Cys Prxs.
Protein S-nitrosylation by S-nitrosothiols (SNO) plays a major
role in eukaryotic cell signaling [34]. Prx1 S-nitrosylation has been
the subject of careful studies [35,36], and recently it was shown
that catalytic cysteines (C-52 and C-173) are S-nitrosylated, thus
preventing oligomerization (and activity) of the enzyme. The
authors also showed that Prx1 undergoes reversible inhibition of
activity upon exposure to relatively high concentrations of Cys-NO
(4100 mM), whereas lower concentrations are sufﬁcient to
inhibit thioredoxin reductase-dependent recycling of Prx1 [37].
S-nitrosylation is usually unstable due to rapid decomposition
Fig. 6. S-homocysteinylation site identiﬁcation in Prx1, by mass spectrometry. RAW264.7 cells were exposed to 500 mM DETA-NO for 16 h. Cell lysates were analyzed by 2-D
SDS-PAGE gel followed by LC–MS/MS. Upper and bottom panels shows respectively MS/MS spectra of unmodiﬁed and modiﬁed Cys-52-containing peptide 38–62 from Prx1;
mass spectra of the 2 triply charged peptides are shown in the right-hand corner, with monoisotopics m/z 1031.8424 (mass accuracy Δm ¼ 0.63 ppm) and 1057.1783 (mass
accuracy Δm ¼ 3.61 ppm). The identiﬁed fragments are annotated on the sequences. Mass difference between y11 and y12 fragments indicates carbamidomethylation
(Δm ¼ 57 Da) and S-homocysteinylation (Δm ¼ 133.01 Da) on cysteine for unmodiﬁed and modiﬁed peptide respectively. Mascot scores of 2 peptides (90 and 63) are
signiﬁcantly higher than the identity threshold [37]. Modiﬁed peptide by homocysteine was not detected in the gel spot after treatment with DTT and iodoacetamide. Shown
are data representative of three independent experiments.
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by light, metals or enzymatic systems [24]. However, Prx1
S-nitrosylation is relatively resistant to denitrosylation by the
Trx/TrxR system [35]. Cys-NO can easily mediate S-nitrosylation
of speciﬁc free thiol groups of proteins through transnitrosylation,
and it has been largely used to study SNO signaling. It was thus
used as a positive control in our study.
To investigate whether the acidic form of Prx1 in cells exposed to
either DETA-NO or Cys-NO is S-nitrosylated, we treated cell lysates
with 5mM ascorbate and 10 mMCuSO4, which selectively reduces SNO
groups [24,38], before performing 2D-gel and immunodetection of the
various forms of 2-Cys Prxs. As shown in Fig. 5A, two acidic satellite
spots of Prx1 were found in samples of Cys-NO treated cells, including
spot X. The more acidic spot (open arrowhead pointing upward)
disappeared upon ascorbate treatment. The acidic satellite spots of
Prx3 and Prx4 (marked by a white arrowhead pointing upward) were
also missing after treatment by ascorbate. As regards Prx2, which is
located around the acidic edge of the gel, the smearing spots seen in
the ascorbate-treated sample suggest that the acidic form of Prx2 was
not totally reduced back to the reduced form. Overall, these data imply
that the four 2-Cys Prxs can be S-nitrosylated in RAW264.7 cells upon
exposure to an S-nitrosothiol. This conclusion was not unexpected
because S-nitrosylation of various Prxs has been detected in many cell
types including RAW264.7 macrophages [35,39], epithelial cells [40–
42], endothelial cells [36], and hepatocytes [43], and it has been shown
that Cys-SNO prevents Prx2 sulﬁnylation through S-nitrosylation of
catalytic cysteines in neurons [17]. The consequence of a treatment by
a diazeniumdiolate like DETA-NO was not anticipated. Diazeniumdio-
lates (“NONOates”) release NO directly as a radical, which is not a
nitrosating species unless it forms nitrous anhydride (N2O3) in the
presence of oxygen or dinitrosyl-iron complexes (DNIC) in the
presence of the labile iron pool (LIP) also referred to as chelatable
iron pool (CIP) [20]. Results in Fig. 5B show that only one acidic form of
Prx1 (spot X), was present and remained after ascorbate/copper
treatment, suggesting that S-nitrosylation of Prx1, if any, was very
limited in cells exposed to DETA-NO. It was previously shown that
treatment of RAW264.7 cells with DEA-NO, another diazeniumdiolate
with a very short half-life (t1/2E2 min at 37 1C and pH 7.4), induces
Prx1 S-nitrosylation [37]. However, DEA-NO, which releases NO as a
high and short burst, was used at a concentration of 500 mM, which
gives a steady-state level NO approximately 20 times higher than that
given by the same concentration of DETA-NO, the slow-releasing NO
donor (t1/2E20h at 37 1C and pH 7.4) used in this study [44]. It is
important to recall that depending on the type of NO donor, release
kinetics, and concentration, the outcome can be quite different [45].
As regards the various forms of 2-Cys Prxs detected in cells stimulated
with IFN-γ and LPS (Fig. 5C), only one spot very nearly vanished upon
ascorbate/copper treatment (open arrowhead pointing up) presuming
S-nitrosylation, whereas two other spots including spot X were
resistant.
To identify the modiﬁcation of Prx1 spot X, we performed mass
spectrometry analyses. The main Prx1 spot and the satellite spot
nearby (X) were picked off the gel, trypsin-digested and subjected
to LC–MS/MS analysis. The error tolerant search in the UniMod
database allowed us to identify one triply charged peptide with a
monoisotopic m/z 1057.1783 (mass accuracy Δm ¼ 3.61 ppm)
corresponding to a homocysteine (Hcy) adduct (þ133.01) on
Cys-52 in spot X. Fig. 6 shows peptide fragmentation spectra.
Mass difference betweenwell visible y11 and y12 fragments indicates
carbamidomethylation (Δm ¼ 57 Da) and S-homocysteinylation
(Δm ¼ 133.01 Da) on cysteine for unmodiﬁed and modiﬁed
peptide respectively. Interestingly, DTT and iodoacetamide treat-
ment of spot X from DETA-NO-exposed cells, before digestion,
only allowed detection of carbamidomethylation but not
S-homocysteinylation of Prx1 Cys-52, suggesting reduction of a
disulﬁde bond. Mammalian Prx1 has four cysteine residues,
Cys-52, Cys-73, Cys-83 and Cys-173. Cys-52 is the peroxidatic
cysteine (Cp) of Prx1. It is worth noting that it was the only one out
the four cysteines, which are present in Prx1 that displayed
homocysteinylation. S-homocysteinylation, a relatively stable
modiﬁcation, may lead to functional consequences for the protein.
In this series of analyses, we have focused on Prx1, and we cannot
therefore exclude that the other 2-Cys Prxs also undergo S-
homocysteinylation. Considering our data showing an ascorbate-
resistant Prx4 leftward spot (Fig. 5B), Prx4 would be the best
candidate.
At this stage, this result requires further validation, e.g., by
immunodetection, but the reproducibility and precision of our mass
spectrometry data challenges us to speculate on the potential impact
of Prx1 S-homocysteinylation. Hcy is an intermediate of the ubiquitous
methionine metabolism [46]. Reported values of the pKa of free
homocysteine at physiological pH are high (E10), which allows
binding to protein cysteine residues with low pKa [47]. However, in
our study, the fact that NO released either by DETA-NO or Cys-NO,
is required to induce S-homocysteinylation, suggests formation of
S-nitroso-Hcy [48] as a prior step toward transnitrosylation to give
Prx1-S-S-Hcy. Alternatively, the formation of SNO-Cp could be favored
by the low pKa of the Cp thiolate anion of the Prx family members [3].
As SNOs are electrophilic, Cp can easily react with other thiols by
transnitrosylation or by disulﬁde formation [49]. S-nitroso-Cp forma-
tion should then favor formation of the mixed disulﬁde Prx1-S-S-Hcy.
In keeping with this hypothesis, reversible thiolation (glutationylation)
of proteins in cells exposed to the diazeniumdiolate PABA-NO has
been reported [50].
N-homocysteinylation of plasma proteins has been largely
documented [51]. However, little is known on the physiological
role of S-homocysteinylation on intracellular proteins [47,52].
S-homocysteinylation of Prx1 at Cys-52 may have incidence on
peroxidase or chaperone activities as well as interaction with
protein partners. To better apprehend the importance of the
addition of an Hcy residue to the catalytic cysteine of Prx1, further
studies will be required to determine the stability of this mod-
iﬁcation, and notably if it is accessible to physiological reducers
like the Trx/Trx reductase system. Notably, whether Hcy may
inhibit peroxidase activity or alternatively protect Prx1 against
peroxide-mediated sulﬁnylation remains a challenging issue.
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